Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Error message

    • Deprecated function: Return type of DatabaseStatementBase::execute($args = [], $options = []) should either be compatible with PDOStatement::execute(?array $params = null): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2246 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::current() should either be compatible with Iterator::current(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::next() should either be compatible with Iterator::next(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::key() should either be compatible with Iterator::key(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::valid() should either be compatible with Iterator::valid(): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::rewind() should either be compatible with Iterator::rewind(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).

    Christopher Palmer

    Christopher Palmer has been an associate editor at MDedge News since 2017. When he's not tidying grammar, he writes short pieces about breaking FDA announcements and approvals, as well as journal articles. He proudly holds a BA in English and philosophy. Follow him on Twitter @cmacmpalm.

    News

    Stillbirth linked to end-stage renal disease

    Author:
    Christopher Palmer
    Publish date: March 7, 2020

    There was also an association between stillbirth and risk for chronic kidney disease.

    • Read More

    News

    Family history of MI may increase CVD mortality after bilateral salpingo-oophorectomy

    Author:
    Christopher Palmer
    Publish date: March 5, 2020

    Removal of the ovaries before the natural age of menopause should be strongly discouraged in women who are not at increased genetic risk for...

    • Read More

    News

    China’s health authorities release large coronavirus case series

    Author:
    Christopher Palmer
    Publish date: February 25, 2020

    The age distribution shows that most of the cases (87%) occurred in patients aged 30-79 years.

    • Read More

    News

    Neurologists report low job satisfaction

    Author:
    Christopher Palmer

    Isolation from others was their top coping strategy, followed by talking with friends and family and exercise.

    • Read More

    News

    Prescription osteoarthritis relief gets OTC approval

    Author:
    Christopher Palmer
    Publish date: February 19, 2020

    The diclofenac sodium topical gel previously known as Voltaren Gel 1% will now be sold over the counter as Voltaren Arthritis Pain.

    • Read More

    News

    Survey queries pulmonologists' happiness at work

    Author:
    Christopher Palmer
    Publish date: February 18, 2020

    Most burned out or depressed pulmonologists would not seek professional help or engage in workplace programs.

    • Read More

    News

    Less than a quarter of endocrinologists happy at work

    Author:
    Christopher Palmer
    Publish date: February 18, 2020

    Most are too busy to seek professional help for their burnout and depression.

    • Read More

    News

    FDA issues MiniMed600 insulin pump recall

    Author:
    Christopher Palmer
    Publish date: February 12, 2020

    A missing or broken retainer ring could lead to hyperglycemia or hypoglycemia, which in some cases can be fatal.

    • Read More

    News

    FDA: Cell phones still look safe

    Author:
    Christopher Palmer
    Publish date: February 11, 2020

    The available evidence does not suggest a causal link between cell phone use and cancer, according to the FDA.

    • Read More

    News

    Fast-acting, mealtime insulin aspart is approved for kids

    Author:
    Christopher Palmer
    Publish date: January 6, 2020

    The mealtime insulin comes with no premeal dosing recommendation.

    • Read More

    News

    Intersubject correlation analyses can be used to pinpoint neural patterns in ADHD

    Author:
    Christopher Palmer
    Publish date: December 15, 2019

    Dovetailing results from this kind of study with those of more conventional designs could yield significant insights into the underpinnings of...

    • Read More

    News

    FDA authorizes customizable automated glycemic controller

    Author:
    Christopher Palmer
    Publish date: December 13, 2019

    The move sets up criteria and requirements for future devices of the same type.

    • Read More

    News

    Abnormal gaze processing found in patients with bipolar disorder

    Author:
    Christopher Palmer
    Publish date: December 12, 2019

    Early-life dysfunctional parental-infant interactions might explain how bipolar patients learn emotion-regulation strategies.

    • Read More

    News

    Brains of MDD patients show alterations in areas tied to positive emotions

    Author:
    Christopher Palmer
    Publish date: December 11, 2019

    “To the best of our knowledge, asymmetric alterations in cortical thickness and subcortical volume in patients with MDD have not yet been reported...

    • Read More

    News

    FDA approves infliximab-axxq for numerous indications

    Author:
    Christopher Palmer
    Publish date: December 6, 2019

    This is the fourth biosimilar for this tumor necrosis factor inhibitor to receive FDA approval.

    • Read More

    Pages

    • « first
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2023 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery